General Description

Blueprint Medicines

Youtube Subscribe

Ticker: BPMC

Sector: Biotechnology

Blueprint Medicines reported a loss of $2.19 per share for the second quarter of 2023, narrower than the Zacks Consensus Estimate of a loss. Shares were down about 10% during pre-market hours on Wednesday.

Extended Summary

Blueprint Medicines

Blueprint Medicines Corp. has generated a BUY signal for shortterm two days back! The share prices have been rising up shortly. The USA share BPMC Blueprint Medicine appears to be moving upwards constantly. Blueprint Medicines (NASDAQ:BPMC) is set to give its latest quarterly earnings report on Tuesday, 2022-05-03. Heres what investors need to know before the announcement. Blueprint Medicines reported a loss of $2.19 per share for the second quarter of 2023, narrower than the Zacks Consensus Estimate of a loss. Shares were down about 10% during pre-market hours on Wednesday. Blueprint Medicines Corp (BPMC) earnings, actual eps, eps estimates & results. blueprint medicines corp (bpmc) Earnings, actual EPS, EPS Estimates & Results Stocktwits Join the conversation! Build your trading network. Blueprint Medicines stock price per share is $64.14 today (as of Aug 1, 2023). What is Blueprint Mediciness Market Cap? (NASDAQ : BPMC) Blueprint Medicine s market cap is $3.88B. Blueprint Medicines Co. opened at $63.12 on Friday. Needham & Company LLC reaffirmed a “buy” rating and set a $57.00 price objective on shares of Blueprint Medicine in a research note on Wednesday, April 19th. Barclays raised their price objective at $44.00 to $46.00 on Tuesday, May 23rd. 19 investment analysts have recommended buying stock in Blueprint Medicines Corp. Overall, the consensus among analysts is to buy stock. Over the course of the last 52 weeks, Blueprint Medicine shares have experienced an increase of 8.99%.

Related Results

January 20, 2024 18:24 (London Time)